Last reviewed · How we verify
Photofrin — Competitive Intelligence Brief
marketed
Photoactivated Radical Generator
Oncology
Live · refreshed every 30 min
Target snapshot
Photofrin (porfimer) — Concordia Labs Inc.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Photofrin TARGET | porfimer | Concordia Labs Inc | marketed | Photoactivated Radical Generator | 1995-01-01 | |
| Oxsoralen-Ultra | METHOXSALEN | Bausch Health | marketed | Photoactivated Radical Generator [EPC] | Cytochrome P450 1A2 | 1954-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Photoactivated Radical Generator class)
- Concordia Labs Inc · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Photofrin CI watch — RSS
- Photofrin CI watch — Atom
- Photofrin CI watch — JSON
- Photofrin alone — RSS
- Whole Photoactivated Radical Generator class — RSS
Cite this brief
Drug Landscape (2026). Photofrin — Competitive Intelligence Brief. https://druglandscape.com/ci/porfimer. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing